Use of a non-specific immunomodulation therapy as a therapeutic vasculogenesis strategy in no-option critical limb ischemia patients.
Marfella R, Luongo C, Coppola A, Luongo M, Capodanno P, Ruggiero R, Mascolo L, Ambrosino I, Sardu C, Boccardi V, Lettieri B, Paolisso G.
Marfella R, et al. Among authors: luongo c, luongo m.
Atherosclerosis. 2010 Feb;208(2):473-9. doi: 10.1016/j.atherosclerosis.2009.08.005. Epub 2009 Aug 8.
Atherosclerosis. 2010.
PMID: 19709658
Clinical Trial.